Dulaglutide

Evidence record

Product and route

Subcutaneous injection.

Approval scope

Trulicity: specified type 2 diabetes populations.

Mechanism

GLP-1 receptor agonist fusion protein.

Evidence

Randomized studies.

Limits

No weight-management indication.

Safety context

Not recommended for severe gastroparesis.

A reading exercise

Treat a short label beside dulaglutide as an invitation to check its meaning. Copy the label, then open the record attached to it and find the passage that supports that wording. Note what the passage names, what boundaries it sets, and which date belongs to the record. The exercise is to draw a box around the label's scope: everything inside must be supported by that passage. If a page uses the label to describe something broader, write down the extra step it has taken. Leave that step as a question until its supporting record is identified.

Questions to take away

1. Which passage in the linked record supports the label's exact wording?
2. What boundaries would you need to include when explaining that label to someone?
3. Does the page extend the label beyond what the identified passage covers?